| 1401/1816 | US=92 / Biol/Mol Sordet O, Pommier Y, Solary E. Established cancer therapies: topoisomerase I poisons and apoptotic topoisomerase I-DNA complexes. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 383-406. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. |
| 1402/1816 | US=92 / Biol/Mol Larsen AK, Skladanowski A. Established cancer therapies: perturbations of cellular functions by topoisomerase II inhibitors. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 407-22. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. TOPOISOMERASE II; AGENTES ANTICANCERIGENOS; DOXORRUBICINA; ETOPOSIDE; MORTE CELULAR; PARADA DO CRESCIMENTO; APOPTOSE; NECROSE; CATASTRIOHE MITOTICO; INDUZIDA POR DROGAS PSEUDOSENESCENCE; AUTOFAGIA |
| 1403/1816 | US=92 / Biol/Mol Woynarowski JM, Woynarowska BA. Established cancer therapies: the significance of poly-targeting in apoptosis induction by alkylating agents and platinum drugs. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 423-63. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. DNA DO ADULTO; DROGAS ALQUILACAO; DROGAS PLATIUM; ALQUILACAO DE PROTEINAS; TADGETING PROTEINA; REGULACAO REDOX |
| 1404/1816 | US=92 / Biol/Mol Klein LE, Horwitz SB. Established cancer therapies: contributions of apoptosis ana senescence to cytotoxicity produced by microtubule-stabilizing agents. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 465-76. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. TAXOL; DISCODERMOLIDE; MICROTUBULOS ACELEROU A SENESCENCIA; AGENTES ESTABILIZADORES MIROTUBULE; APOPTOSE; CATASTROFE MITOTICA |
| 1405/1816 | US=92 / Biol/Mol Deininger M. Established cancer therapies: tyrosine kinase inhibitors. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 477-508. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. TERAPIA-ALVO; BCR-ABL; FLT3; EGFR; TYROSISE INIBITORS QUINASE; IMATINIB; GEFITINIB; ERLOTINIB; CANCER; LEUCEMIA |
| 1406/1816 | US=92 / Biol/Mol Furman RR, Leonard JP, Decter J, Coleman M. Recent and developing cancer therapies: monoclonal antibodies in lymphomas. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 511-36. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. |
| 1407/1816 | US=92 / Biol/Mol Doll JA, Hobbs JE, Soff GA. Recent and developing cancer therapies: role of apoptosis in anti-angiogenic cancer therapies. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 537-55. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. ANGIOGENESE; APOPTOSE; THROMBOSPONDIN-1; CELULAS ENDOTELIAIS; ANTI-ANGIOGENICO |
| 1408/1816 | US=92 / Biol/Mol Oleinick NL, Morris RL, Nieminem AL. Recent and developing cancer therapies: photodynamic therapy-induced apoptosis. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 557-78. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. TERAPIA FOTODINAMICA; FOTOSSENSIBILIZADOR; MITOCONDRIA LISOSSOMO; RETICULO ENDOPLASMATICO; APOPTOSE |
| 1409/1816 | US=92 / Biol/Mol Fulda S, Debatin KM. Recent and developing cancer therapies: modulation of TRAIL signaling for cancer therapy. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 579-91. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. |
| 1410/1816 | US=93 / Biol/Mol Peek Junior RM. Infectious agents, cytokines, and cancer: helicobacter pylori and cytokines in the genesis of gastric cancer. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 3-26. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2. AGENTES INFECCIOSOS; CITOCINAS; CANCER; HELICOBACTER PYLORI; CITOCINAS NA GENESE DO CANCER GASTRICO |
| 1411/1816 | US=93 / Biol/Mol Lairmore M, Ratner L. Infectious agents, cytokines, and cancer: HTLV-1, cytokines, and cancer. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 27-51. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2. |
| 1412/1816 | US=93 / Biol/Mol Jenkins FJ, Hensler HR. Infectious agents, cytokines, and cancer: herpesviruses, cytokines, and cancer. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 53-67. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2. AGENTES INFECCIOSOS; CITOCINAS; CANCER; HERPESVIRUSES; CITOCINAS |
| 1413/1816 | US=93 / Biol/Mol DeWitte M, Shealy DJ, Nakada MT, Anderson GM. Cytokines and carcinogenesis: tumor necrosis factor and cancer. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 71-89. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2. AGENTES INFECCIOSOS; CITOCINAS; CANCER; FATOR DE NECROSE TUMORAL |
| 1414/1816 | US=93 / Biol/Mol Bonine-Summers AR, Law BK, Moses HL. Cytokines and carcinogenesis: transforming growth factor-B and cancer. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 91-111. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2. CITOCINAS; CARCINOGENESE; FATOR DE CRESCIMENTO TRANSFORMANTE-B; CANCER |
| 1415/1816 | US=93 / Biol/Mol Lotze MT. Cytokines and carcinogenesis: interleukin-1 family of cytokines and cancer. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 113-33. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2. CITOCINAS; CARCINOGENESE; INTERLEUCINA-1 DA FAMILIA DE CITOQUINAS; CANCER |
| 1416/1816 | US=93 / Biol/Mol Kawakami K, Puri RK. Cytokines and carcinogenesis: interleukin-4/13 and cancer. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 135-53. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2. |
| 1417/1816 | US=93 / Biol/Mol Nishimoto N. Cytokines and carcinogenesis: interleukin-6 and Castleman's disease. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 155-63. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2. CITOCINAS; CARCINOGENESE; INTERLEUCINA-6; DOENCA DE CASTLEMAN |
| 1418/1816 | US=93 / Biol/Mol Fujii SI, Lotze MT. Cytokines and carcinogenesis: interleukin-10 (IL-10). In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 165-79. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2. |
| 1419/1816 | US=93 / Biol/Mol Chauhan D, Hideshima T, Anderson KC. Cytokines and carcinogenesis: cytokines in multiple myeloma. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 181-97. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2. |
| 1420/1816 | US=93 / Biol/Mol Fehniger TA, Cooper MA, Caligiuri MA. Cytokines and carcinogenesis: in vivo murine cytokine models and the genesis of cancer. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 199-209. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2. CITOCINAS; CARCINOGENESE; MODELOS DE MURINO IN VIVO DE CITOCINAS; GENESE DO CANCER |